The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases

• Published in: Frontiers in physiology Vol. 13; p. 907358
• Main Authors: Liu, Lifei, Liu, Yuhao, Huang, Mei, Zhang, Miao, Zhu, Chenyu, Chen, Xi, Bennett, Samuel, Xu, Jiake, Zou, Jun
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 11.07.2022
• Subjects: asprosin; exercise; metabolism disease; obesity; pcos; Physiology; T2DM
• ISSN: 1664-042X; 1664-042X
• DOI: 10.3389/fphys.2022.907358

Fibrillin is the major constituent of extracellular microfibrils, which are distributed throughout connective tissues. Asprosin is derived from the C-terminal region of the FBN1 gene, which encodes profibrillin that undergoes cleavage by furin protein. In response to fasting with low dietary glucose, asprosin is released as a secreted factor from white adipose tissue, and is transported to the liver for the mediation of glucose release into the blood circulation. Through binding to OLFR734, an olfactory G-protein-coupled receptor in liver cells, asprosin induces a glucogenic effect to regulate glucose homeostasis. Bioinformatics analyses revealed that the FBN1 gene is abundantly expressed in human skeletal muscle-derived mesoangioblasts, osteoblast-like cells, and mesenchymal stem cells, indicating that the musculoskeletal system might play a role in the regulation of asprosin expression. Interestingly, recent studies suggest that asprosin is regulated by exercise. This timely review discusses the role of asprosin in metabolism, its receptor signalling, as well as the exercise regulation of asprosin. Collectively, asprosin may have a vital regulatory effect on the improvement of metabolic disorders such as diabetes mellitus and obesity via exercise.